Pfizer Inc said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with internationa
Today, the FDA issued an EUA for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients.